NCT05825157View on ClinicalTrials.gov

Prospective Evaluation of Combination Therapy for Upper Extremity Lymphedema

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2028

Conditions
Lymphedema Arm
Interventions
DEVICE

BioBridge

Fibralign BioBridge is a thread-like, multi-lumen scaffold consisting of highly aligned collagen fibrils, optimized to encourage the endothelial cell attachment,alignment and migration that are prerequisites to new vessel formation. BioBridge is a device made from highly purified, medical-grade porcine collagen.

All Listed Sponsors
lead

Stanford University

OTHER

NCT05825157 - Prospective Evaluation of Combination Therapy for Upper Extremity Lymphedema | Biotech Hunter | Biotech Hunter